Amalgamated Bank Biotechnology

Amalgamated Bank

$12.6 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ALDX Aldeyra Therapeutics, Inc.	$303M	$6,000 0.0% of portfolio	1,571	Q1 2024 Reduced 76.18%
RCKT Rocket Pharmaceuticals, Inc.	$244M	$6,000 0.0% of portfolio	2,657	Q1 2025 Added 24.16%
XOMA Xoma Corp	$438M	$6,000 0.0% of portfolio	247	Q1 2024 Reduced 61.29%
FENC Fennec Pharmaceuticals Inc.	$231M	$6,000 0.0% of portfolio	821	Q1 2025 Added 34.15%
PGEN Precigen, Inc.	$747M	$6,000 0.0% of portfolio	4,621	Q2 2024 Added 39.9%
OLMA Olema Pharmaceuticals, Inc.	$327M	$6,000 0.0% of portfolio	1,411	Q1 2025 Added 55.74%
FDMT 4 D Molecular Therapeutics, Inc.	$222M	$6,000 0.0% of portfolio	1,738	Q1 2025 Added 27.51%
CRDF Cardiff Oncology, Inc.	$87.5M	$6,000 0.0% of portfolio	2,009	Q1 2025 Added 48.27%
GLUE Monte Rosa Therapeutics, Inc.	$324M	$6,000 0.0% of portfolio	1,425	Q1 2025 Added 43.22%
TYRA Tyra Biosciences, Inc.	$517M	$6,000 0.0% of portfolio	701	Q1 2025 Added 65.33%
HUMA Humacyte, Inc.	$158M	$6,000 0.0% of portfolio	3,034	Q1 2025 Added 39.88%
ADCT Adc Therapeutics Sa	$248M	$6,000 0.0% of portfolio	2,422	Q2 2024 New
ENTA Enanta Pharmaceuticals Inc	$155M	$5,000 0.0% of portfolio	667	Q1 2024 Reduced 64.43%
SCPH Sc Pharmaceuticals Inc.	$154M	$5,000 0.0% of portfolio	1,358	Q1 2025 Added 39.57%
ALLO Allogene Therapeutics, Inc.	$163M	$5,000 0.0% of portfolio	4,430	Q1 2025 Added 60.16%
YMAB Y M Abs Therapeutics, Inc.	$376M	$5,000 0.0% of portfolio	1,217	Q1 2024 Reduced 70.47%
TRDA Entrada Therapeutics, Inc.	$166M	$5,000 0.0% of portfolio	852	Q1 2025 Added 18.17%
LIFE A Tyr Pharma Inc	$53.2M	$5,000 0.0% of portfolio	2,971	Q2 2025 New
ELDN Eledon Pharmaceuticals, Inc.	$32.2M	$5,000 0.0% of portfolio	2,002	Q2 2025 New
PBYI Puma Biotechnology, Inc.	$214M	$4,000 0.0% of portfolio	1,432	Q2 2024 New
VYGR Voyager Therapeutics, Inc.	$167M	$4,000 0.0% of portfolio	1,382	Q2 2024 Added 29.04%
KOD Kodiak Sciences Inc.	$487M	$4,000 0.0% of portfolio	1,154	Q1 2024 Reduced 60.07%
LRMR Larimar Therapeutics, Inc.	$173M	$4,000 0.0% of portfolio	1,452	Q1 2025 Added 67.86%
CADL Candel Therapeutics, Inc.	$142M	$4,000 0.0% of portfolio	980	Q1 2025 Added 42.86%
FATE Fate Therapeutics Inc	$92.2M	$3,000 0.0% of portfolio	2,912	Q1 2024 Reduced 60.9%
ALEC Alector, Inc.	$244M	$3,000 0.0% of portfolio	2,540	Q2 2024 Added 16.57%
TARA Protara Therapeutics, Inc.	$34.9M	$3,000 0.0% of portfolio	1,103	Q2 2025 New
NKTX Nkarta, Inc.	$95.9M	$3,000 0.0% of portfolio	1,826	Q1 2025 Added 62.31%
FHTX Foghorn Therapeutics Inc.	$208M	$3,000 0.0% of portfolio	681	Q1 2024 Reduced 76.3%
DSGN Design Therapeutics, Inc.	$327M	$3,000 0.0% of portfolio	1,176	Q1 2024 Reduced 59.86%
THRD Third Harmonic Bio, Inc.	$217M	$3,000 0.0% of portfolio	665	Q1 2024 Reduced 72.31%
NVCT Nuvectis Pharma, Inc.	$90.9M	$3,000 0.0% of portfolio	440	Q2 2025 New
PLX Protalix Bio Therapeutics, Inc.	$96.5M	$3,000 0.0% of portfolio	2,381	Q2 2025 New
DMAC Dia Medica Therapeutics Inc.	$186M	$3,000 0.0% of portfolio	902	Q2 2025 New
CHRS Coherus Bio Sciences, Inc.	$98.7M	$2,000 0.0% of portfolio	3,609	Q2 2024 Added 39.88%
GLSI Greenwich Life Sciences, Inc.	$147M	$1,000 0.0% of portfolio	207	Q2 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	1,682	Q3 2024 Added 105.62%
INMB Inmune Bio, Inc.	$35.9M	$0 0.0% of portfolio	422	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.